“…However, bacterial resistance to each of these agents has been demonstrated in various parts of the world (Farrar, 1985) and alternatives are, therefore, necessary. In clinical trials where they have been evaluated as either treatment or prophylaxis, ciprofloxacin and norfloxacin have been shown to be effective (Johnson et al, 1986;DuPont, Corrado & Sabbaj, 1987;Ericsson et al, 1987;Lolekha et al, 1988;Scott et al, 1990). Fleroxacin is a new 6,8-difluoro-4-quinolone which also exhibits a broad spectrum of antibacterial activity (Hohl, von Graevenitz & Zollinger-Iten, 1988).…”